July 1, 2024
The MUC-1 vaccine tecemotide plus standard neoadjuvant systemic therapy was shown to notably improve distant relapse-free survival and overall survival rates in breast cancer patients, in […]
July 1, 2024
(Reuters) -AstraZeneca said on Monday that the European Union drug regulator has accepted a market authorisation application for its investigational COVID-19 prevention drug, sipavibart, for an […]
July 1, 2024
Lying in an ambulance, her nose busted, gums sliced to the bone after hitting a barricade on her bike, Katie Zaferes had one question on her […]
July 1, 2024
On June 6, federal legislation was introduced in Canada that would establish common standards for sharing information and offer patients and their providers easier access to […]
July 1, 2024
TOPLINE: Medicaid acceptance among pediatric dermatologists varies significantly by practice type and region, with the highest rate among academic practices. METHODOLOGY: Researchers identified 352 actively practicing […]
June 28, 2024
LYON, France — The drug zodasiran (formerly ARO-ANG3), which targets the production of a liver protein, substantially lowers triglyceride and a range of lipoprotein levels in […]
June 28, 2024
LYON, FRANCE — The anti-obesity drug semaglutide is associated with significant reductions in the inflammatory marker high-sensitivity C-reactive protein (CRP), even in patients who do not […]
June 28, 2024
A work group convened by the Alzheimer’s Association has released revised biology-based criteria for the diagnosis and staging of Alzheimer’s disease (AD), including a new biomarker […]
June 28, 2024
The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorization for the mRNA respiratory syncytial virus (RSV) […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487
Next page